Feedback

A high-efficiency automatic pressure-relief drug transfer device for anticancer medications with superior closed performance

Affiliation
Department of Pharmacy , The Affiliated Hospital of Guangdong Medical University ,Zhanjiang ,China
Xie, Liming;
Affiliation
Department of Pharmacy , The Affiliated Hospital of Guangdong Medical University ,Zhanjiang ,China
Chen, Guanfeng;
Affiliation
School of Ocean and Tropical Medicine ,Guangdong Medical University ,Zhanjiang ,Guangdong ,China
Ouyang, Qianqian;
Affiliation
School of Ocean and Tropical Medicine ,Guangdong Medical University ,Zhanjiang ,Guangdong ,China
Quan, Weiyan;
Affiliation
Department of Pharmacy , The Affiliated Hospital of Guangdong Medical University ,Zhanjiang ,China
Xie, Xiaoming;
Affiliation
Department of Pharmacy , The Affiliated Hospital of Guangdong Medical University ,Zhanjiang ,China
Chen, Xiaoling;
Affiliation
School of Chemistry and Environmental Science ,Guangdong Ocean University ,Zhanjiang ,China
Li, Lefan;
Affiliation
School of Chemistry and Environmental Science ,Guangdong Ocean University ,Zhanjiang ,China
Li, Sidong;
Affiliation
Guangdong Jianliyuan Medical Technology Co., Ltd. ,Zhanjiang ,China
Chen, Rizhi;
Affiliation
Guangdong Jianliyuan Medical Technology Co., Ltd. ,Zhanjiang ,China
Luo, Rongqiong;
Affiliation
Department of Pharmacy , The Affiliated Hospital of Guangdong Medical University ,Zhanjiang ,China
Qiu, Zhiqing

Objective Preventing exposure to hazardous drugs is crucial for healthcare workers to avoid health risks. To mitigate healthcare workers’ risks when handling hazardous drugs, we developed a novel closed-system drug-transfer device (CSTD) called CSTD(JLY). This CSTD has an automatic pressure-relief structure. Hence, it can significantly decrease the resistance in the push/pull of a piston rod if an operator transfers drugs, thereby reducing the burden on the hands of the operator during drug transfer. Methods We investigated the closed performance of the novel CSTD (JLY) by comparing it with the performance of a syringe. We selected a simulation drug (fluorescein sodium), commonly used drugs (lansoprazole, nimodipine, and tropisetron), and a commonly used anti-cancer agent (cyclophosphamide) to conduct exposure evaluation. Results Compared with a syringe, CSTD(JLY) could reduce drug leakage significantly. Our novel CSTD with an automatic pressure-relief structure had superior closed performance. CSTD(JLY) could solve the problem of liquid-drug leakage during drug transfer. Conclusion This feature could reduce the exposure risk healthcare workers and patients.

Cite

Citation style:
Could not load citation form.

Access Statistic

Total:
Downloads:
Abtractviews:
Last 12 Month:
Downloads:
Abtractviews:

Rights

License Holder: Copyright © 2025 Xie, Chen, Ouyang, Quan, Xie, Chen, Li, Li, Chen, Luo and Qiu.

Use and reproduction: